Biotech giant Seattle Genetics is at the Mt. Rushmore of cancer research. This organization is hands down the best in the business and this isn’t by chance. Seattle Genetics has been around since 1998 and it has steadily made it’s mark in this exclusive industry with scientific innovation, rigorous research, and drug development. It would be hard to find a more progressive acting and efficient company than this. Dr. Clay Siegall is the man with the plan, literally. This guy is the commander in chief of this biotech giant. Dr. Siegall is the epitome of success thanks to his stellar reputation, long list of accomplishments, and his strong passion for saving lives. The guy is known throughout the industry as a philanthropist, doctor, scientist, author, and a guest speaker. He’s pretty much a jack of all trades kind of guy with a heart of pure gold.
Dr. Siegall has been in the business for many years and he’s worked with some of the finest of organizations such as The National Institute of Health, The National Cancer Institute , and Bristol Myers Squibb. The good doctor has a broad educational background as well with a (BS) in Zoology and a Ph.D in Genetics. With the guidance of Dr. Siegall on board, this organization will continue to save lives and there are well over 800 employees on this extraordinary roster. This type of success has helped the company’s stock triple in over a five year span. There are numerous advanced cancer medication waiting it the pipeline, which will result in the hiring of at least 200 more employees. What other cancer research company can say this about themselves are actually do what Seattle Genetics has done?
Dr. Siegall has also helped to raise $1.2 Billion through public/private fundraising. All in all, Cancer research is thriving and this deadly disease is being rocked back on it’s heals. Through scientific innovation, this disease will hopefully be taken out and eradicated for good.